Accessibility Menu
Longevity Health logo

Longevity Health(OTC) XAGE

Market Cap$522.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-100%
5 YearN/A
1 Year-95%
1 Month-31%
$0.25
+16.21%
+0.03Today
Longevity Health last closing stock price
MetricPriceDate
Last closeUSD 0.212026-07-24
Longevity Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-12.08%USD 0.242026-07-17
1 month-30.83%USD 0.312026-06-24
3 month-32.15%USD 0.312026-04-24
Year to date-29.88%USD 0.302025-12-31
1 year-94.8%USD 4.062025-07-24
3 year-99.81%USD 112.502023-07-25
Since inception-99.93%USD 292.502021-09-23

Longevity Health Financials at a Glance

Market Cap

$522.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.79M

Net Income (TTM)

-$6.83M

EPS (TTM)

-$4.31

P/E Ratio

-0.05

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.25

Volume

4,077

Open

$0.23

Previous Close

$0.25

Daily Range

$0.21 - $0.25

52-Week Range

$0.21 - $4.20

Estimated Earnings Date

Aug 13, 2025

XAGE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Longevity Health

Longevity Health Holdings makes skincare and haircare products for people seeking science-based cosmetic solutions. Its products help with skin recovery after treatments and support hair appearance. The company also develops materials for bone and tissue healing, though this work is now paused.

Products and Services

  • Elevai Exosomes: Skincare and haircare products using nano-sized vesicles, mainly for post-treatment support and daily care (majority of 2025 revenue).
  • Carmell Secretome: Skincare lines with growth factors and proteins from human platelets, targeting facial and neck care (minor 2025 revenue).
  • Bone Healing Accelerant: Plasma-based material for bone repair, with development currently paused (no 2025 revenue).
  • Tissue Healing Accelerant: Product for wound and hair loss support, also paused (no 2025 revenue).

Growth and Expansion

  • Acquired Elevai Skincare in January 2025, adding new product lines.
  • Launched Elevai Renew Scalp Serum and other Elevai products in 2025 and 2026.
  • Entered licensing agreement with Yuva BioSciences for haircare compounds in 2025.
  • Terminated planned mergers with THPlasma and 20/20 Biolabs in 2025.
  • Raised capital through private placements and equity offerings in 2025 and 2026.

What Makes Longevity Health Holdings Stand Out

The company uses proprietary plasma-based and exosome technology in its products. It focuses on physician-dispensed sales, targeting medical professionals and spas. Strict quality controls and unique ingredient delivery methods support its market approach.

Five Things You Need to Know

  • Net sales were $1.91 million in FY 2025, up 3,701% from FY 2024.
  • Gross profit reached $1.09 million in FY 2025, up 2,390% year-over-year.
  • Operating expenses rose 63% to $8.2 million in FY 2025.
  • Net loss improved to $6.9 million in FY 2025 from $10.4 million in FY 2024.
  • Cash position was $0.71 million as of December 31, 2025, with negative working capital.

Bottom Line

Longevity Health Holdings shifted from bone healing to cosmetic products after acquiring Elevai. The company faces financial challenges but continues to adapt its business model.

AI Generated • Apr 16, 2026

Industry

Biotechnology

Sector

Health Care

Employees

10

CEO

Janakiram Ajjarapu, MBA

Website

www.carmellcosmetics.com

Headquarters

Pittsburgh, PA 15203, US

XAGE Financials

Key Financial Metrics (TTM)

Gross Margin

57.11%

Operating Margin

-397.16%

Net Income Margin

-380.73%

Return on Equity

133.44%

Return on Capital

N/A

Return on Assets

-415.93%

Earnings Yield

-20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$522.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.48M

Volume

4.08K

Avg. Volume

1.38K

Financials (TTM)

Gross Profit

$1.02M

Operating Income

-$7.13M

EBITDA

-$6.70M

Operating Cash Flow

-$3.06M

Capital Expenditure

-$14.22K

Free Cash Flow

-$3.08M

Cash & ST Invst.

$313.40K

Total Debt

$400.62K

Longevity Health Performance Analysis

Longevity Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 50,318N/A
20252025-12-31USD 1,912,8113701.4%
Longevity Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-1.3%
Q32025-09-30-15.4%
Q42025-12-3111.1%
Q12026-03-31-17.2%
Longevity Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -164.0750073.3%
20232023-12-31USD -43.88-73.3%
20242024-12-31USD -16.57-62.2%
20252025-12-31USD -4.83-70.9%
Longevity Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-25.3%
Q32025-09-30-820.2%
Q42025-12-31-45.8%
Q12026-03-3138.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$391.76K

-23.2%

Gross Profit

$199.71K

-26.0%

Gross Margin

50.98%

N/A

Market Cap

$522.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$52.23K

N/A

Employees

10

N/A

Net Income

-$1.43M

+4.9%

EBITDA

-$1.49M

-4.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$313.40K

-59.3%

Total Debt

$400.62K

-23.2%

Accounts Receivable

$48.67K

-87.7%

Inventory

$734.97K

-46.7%

Long Term Debt

$188.16K

-34.8%

Short Term Debt

$212.45K

-8.8%

Return on Assets

-4.16%

N/A

Return on Invested Capital

1.06%

N/A

Free Cash Flow

-$485.29K

+35.5%

Operating Cash Flow

-$485.29K

+35.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CCMConcord Medical Services Holdings Limited
$4.49+4.30%
SCNIScinai Immunotherapeutics Ltd.
$0.25+7.30%
HEPAHepion Pharmaceuticals, Inc.
$0.07+21.87%
ZVSAZyVersa Therapeutics, Inc.
$0.12+9.43%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
AALAmerican Airlines Group
$14.95+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%

Questions About XAGE

What is the current price of Longevity Health?

Longevity Health is trading at $0.25 per share.

What is the 52-week range for Longevity Health?

Over the past 52 weeks, Longevity Health has traded between $0.21 and $4.20.

How much debt does Longevity Health have?

As of the most recent reporting period, Longevity Health reported total debt of $400.62K.

How much cash does Longevity Health have on hand?

Longevity Health reported $313.40K in cash and cash equivalents in its most recent financial results.

What is Longevity Health’s dividend yield?

Longevity Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services